195 related articles for article (PubMed ID: 31670178)
21. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
22. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
23. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
25. Drug transport modeling in solid tumors: A computational exploration of spatial heterogeneity of biophysical properties.
Salavati H; Pullens P; Ceelen W; Debbaut C
Comput Biol Med; 2023 Sep; 163():107190. PubMed ID: 37392620
[TBL] [Abstract][Full Text] [Related]
26. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
[TBL] [Abstract][Full Text] [Related]
27. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J
ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254
[TBL] [Abstract][Full Text] [Related]
28. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.
Lei Y; Hamada Y; Li J; Cong L; Wang N; Li Y; Zheng W; Jiang X
J Control Release; 2016 Jun; 232():131-42. PubMed ID: 27046157
[TBL] [Abstract][Full Text] [Related]
29. Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles.
Curtis LT; Wu M; Lowengrub J; Decuzzi P; Frieboes HB
PLoS One; 2015; 10(12):e0144888. PubMed ID: 26660469
[TBL] [Abstract][Full Text] [Related]
30. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
[TBL] [Abstract][Full Text] [Related]
31. 'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.
Fang Z; Wan LY; Chu LY; Zhang YQ; Wu JF
Expert Opin Drug Deliv; 2015; 12(12):1943-53. PubMed ID: 26193970
[TBL] [Abstract][Full Text] [Related]
32. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
33. A Computational/Experimental Assessment of Antitumor Activity of Polymer Nanoassemblies for pH-Controlled Drug Delivery to Primary and Metastatic Tumors.
Curtis LT; Rychahou P; Bae Y; Frieboes HB
Pharm Res; 2016 Oct; 33(10):2552-64. PubMed ID: 27356524
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
35. Extracellularly activatable nanocarriers for drug delivery to tumors.
Abouelmagd SA; Hyun H; Yeo Y
Expert Opin Drug Deliv; 2014 Oct; 11(10):1601-1618. PubMed ID: 24950343
[TBL] [Abstract][Full Text] [Related]
36. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
Danhier F; Feron O; Préat V
J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
[TBL] [Abstract][Full Text] [Related]
37. Simulation of transvascular transport of nanoparticles in tumor microenvironments for drug delivery applications.
Shabbir F; Mujeeb AA; Jawed SF; Khan AH; Shakeel CS
Sci Rep; 2024 Jan; 14(1):1764. PubMed ID: 38242952
[TBL] [Abstract][Full Text] [Related]
38. Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model.
Stylianopoulos T; Soteriou K; Fukumura D; Jain RK
Ann Biomed Eng; 2013 Jan; 41(1):68-77. PubMed ID: 22855118
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling.
Sims LB; Frieboes HB; Steinbach-Rankins JM
Int J Nanomedicine; 2018; 13():2709-2727. PubMed ID: 29760551
[TBL] [Abstract][Full Text] [Related]
40. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery.
Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y
Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
